Peripheral site acetylcholinesterase inhibitors targeting both inflammation and cholinergic dysfunction
Authors:
- 1 May 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (9) , 2987-2990
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosisCell Death & Differentiation, 2009
- Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic diseaseCytokine, 2009
- Cytokines and Cytokine Profiles in Human Autoimmune Diseases and Animal Models of AutoimmunityMediators of Inflammation, 2009
- Donepezil in the treatment of patients with Alzheimer’s diseaseExpert Review of Neurotherapeutics, 2009
- The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritisNature Reviews Rheumatology, 2009
- Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathwayBrain, Behavior, and Immunity, 2009
- Rivastigmine Transdermal Patch: Role in the Management of Alzheimer's DiseaseThe Consultant Pharmacist, 2008
- An alternative topical treatment of osteoarthritis of the knee with cutaneous diclofenac solutionExpert Opinion on Pharmacotherapy, 2008
- Cholinesterase inhibitors improve survival in experimental sepsis: A new way to activate the cholinergic anti-inflammatory pathway*Critical Care Medicine, 2008
- Overcoming the Stratum Corneum: The Modulation of Skin PenetrationSkin Pharmacology and Physiology, 2006